Cycle time is the unit of value for an Epson SCARA robot. The LS series hits sub-300-millisecond pick-and-place cycles in optimized applications, and when your line runs thousands of cycles per shift, the difference between a 280ms cycle and a 320ms cycle adds up to tens of thousands of parts per year. That throughput edge is why Epson's SCARA lineup dominates electronics assembly lines, pharmaceutical blister packaging, and consumer goods kitting operations. The financing question is simple: does the cell payment fit inside the throughput gain? In the price bracket where Epson arms live, it almost always does.
We finance the Epson LS-Series SCARA arms and Epson's C-series six-axis arms for applications across assembly, dispensing, inspection, and packaging. Complete cells including arms, controllers, vision, and integration typically run $75k-$200k, a range where application-only financing is the default path for qualified buyers. Epson competes most directly with Yamaha Robotics in SCARA applications; both are Japanese brands with strong precision assembly credentials and a large installer base in electronics manufacturing.
Epson Robot Lines: SCARA and Six-Axis
Epson's robotics division has concentrated on SCARA arms since entering the market, and that focus shows in the product depth. Their six-axis line is more recent but growing quickly.
- LS series SCARA (compact and mid-range): The LS6, LS10, and LS20 models cover payload capacities from 6 kg to 20 kg with arm lengths from 225mm to 850mm. The LS series uses Epson's RC90 or RC700 controller, which offers Windows-based programming through Epson RC+ software and integrates with most standard PLC platforms. The LS3 compact model at 225mm arm length is particularly popular in pharmaceutical and cosmetics blister-pack lines where arm-to-arm spacing is tight.
- T series (cost-effective SCARA for light applications): Epson's entry-level SCARA line, with 1-3 kg payload and a simplified built-in controller that reduces the total system cost. The T3 is a common first-robot for small assembly operations that want to automate a single station without the overhead of a full RC90 system.
- C4 and C8 six-axis arms: Epson entered the six-axis market with compact arms covering 4 kg and 8 kg payload, designed for applications where a SCARA's planar motion is insufficient. Material dispensing, complex assembly paths, and irregular-surface inspection are common C4 and C8 applications.
- N series (autonomous mobile robot): Epson has expanded into autonomous mobile robot platforms under the N series brand, a separate category from the stationary arms but financeable under the same structure for buyers adding intralogistics automation.
Epson robots are frequently specified in cleanroom environments. IP54 and cleanroom-rated variants are available across most of the LS series lineup, relevant for pharmaceutical and semiconductor assembly applications where particle control matters.
What Qualifies for Epson Robot Financing
Epson robot projects in the $50k-$400k range qualify for application-only financing, which means no tax returns and no audited financial statements. The requirements are a completed credit application, three months of bank statements showing consistent business activity, and a purchase invoice or integrator quote. Businesses with at least two years of operating history and reasonably clean commercial credit typically see approvals within 24-48 hours.
Common Epson financing scenarios include:
- Electronics assembly lines adding one to four LS series SCARA arms for PCB handling or connector insertion, typically $80k-$180k with integration.
- Pharmaceutical packaging facilities adding LS SCARA cells for blister pack loading, $100k-$220k with vision and tooling included.
- Contract manufacturers adding an Epson cell to serve a specific customer program, where the program contract provides clear revenue visibility for the lender.
- Food and consumer goods operations adding high-speed pick-and-place cells for kitting or portion packaging, $75k-$150k total project cost.
Buyers with B credit (prior slow payments, a resolved collection, or a satisfied tax lien) can still qualify. The terms will reflect the credit profile, but Epson's asset quality and mid-range price point make these deals workable for lenders experienced in electronics and semiconductor automation.
The SCARA Market and Where Epson Competes
SCARA robots are the dominant format for horizontal assembly, pick-and-place, and dispensing applications. Epson competes in this space alongside Yamaha Robotics, Denso, and Mitsubishi Electric, all Japanese manufacturers with strong SCARA lineups. Epson differentiates on controller software usability (RC+ is regarded as approachable for programmers without a deep robotics background) and the compact form factor of the LS series for tight cell installations.
Buyers in San Jose and Silicon Valley electronics and semiconductor supply chains have historically been heavy Epson users, drawn by the SCARA performance and the cleanroom-ready designs for semiconductor wafer handling and microelectronics assembly. That installed base supports Epson's secondary market in the region, which benefits FMV lease structures by maintaining credible residual values at term end.
For buyers considering both SCARA and six-axis arms for different stations on the same line, we can finance both in a single transaction. Mixing arm types within a cell is common in complex assembly, and the financing structure is straightforward as long as the total cell cost and the integrator's scope of work are clearly documented.
Project planning
Frequently Asked Questions
Can I finance an Epson T3 SCARA that costs only $18k? It is below your stated minimum.
The T3 alone is below our $50k minimum, but most T3 deployments include a controller, vision system, and integration services that push the total cell cost above the threshold. If the total project cost is below $50k, that deal is typically a cash purchase or a vendor credit line through the integrator rather than third-party financing.
Our Epson LS10 cell includes a third-party vision system, not Epson's own vision package. Can the vision system be financed?
Yes. Third-party vision systems from Cognex, Keyence, or other vendors are financeable as part of the cell when they are part of the original cell build. We need the full integrator invoice that itemizes both the Epson arm and the vision system.
What is the residual value of a two-year-old Epson LS6 at the end of an FMV lease?
We do not publish residual tables, but Epson SCARA arms in the LS series hold reasonable secondary market values because the brand is widely specified and integrators are familiar with the controller. The lender sets the residual at lease inception based on their assessment of the model's market value at term end. We can get you an FMV lease quote so you see the actual residual assumption being used.
We are buying four Epson LS6 arms for a new cell at once. Does quantity affect the deal structure?
Buying multiple arms in a single cell is a single transaction. Four LS6 arms with integration will comfortably exceed the $100k threshold and qualifies for straightforward application-only terms. The quantity does not add complexity to the financing.
Can a pharmaceutical company finance an Epson cleanroom arm with IP54-rated variants?
Yes. Cleanroom-rated and IP-rated Epson variants finance the same way as standard arms. The modestly higher per-unit cost is simply part of the total cell cost in the financing package. Pharma companies typically have strong financials that make the approval straightforward.
Ready for financing options?
Get Epson SCARA Financing Terms
Share the Epson model and cell scope. We come back with real terms within 24-48 hours and most deals fund in one to two weeks. Application takes about ten minutes.